NASHVILLE, TN
September 26-27, 2017
Omni Hotel
AN ACTION-ORIENTED SUMMIT ON THE DATA AND DIGITAL INFRASTRUCTURE PRECISION MEDICINE NEEDS TO THRIVE
Precision Medicine is facing significant barriers to broad acceptance and implementation.
Solutions must carefully consider the big picture and the practical realities of a complex, multi-stakeholder environment.
Leaders in this ecosystem currently do not have a combined forum to discuss and define the formation and growth of the Genetic Health Information Network.
Precision Medicine is facing significant barriers to broad acceptance and implementation.
Solutions must carefully consider the big picture and the practical realities of a complex, multi-stakeholder environment.
Leaders in this ecosystem currently do not have a combined forum to discuss and define the formation and growth of the Genetic Health Information Network.
An intimate meeting of influential leaders from across in the Genetic Health Information Network
Representing all stakeholders in this ecosystem, including
- Health plans
- Clinicians
- Hospital systems
- Researchers
- Policy makers
- Patients & Advocates
- Laboratories
- IT Vendors
- Pharma
Organizing Committee
(in alphabetical order)
Mara Aspinall
CEO
Health Catalysts
Michael Astion, MD, PhD
Medical Director, Department of Laboratories
Seattle Children’s Hospital
Suzanne Belinson, PhD, MPH
Executive Director
Blue Cross Blue Shield Association
Carlos Bustamante, PhD
Chair, Department of Biomedical Data Science
Stanford University
Gillian Hooker, PhD, ScM, LCGC
VP, Clinical Development
Concert Genetics
Howard Levy, MD, PhD
Associate Professor of Medicine
Johns Hopkins Medicine
Lee N. Newcomer, MD, MHA
SVP, Oncology and Genetics
UnitedHealthcare
Robert Nussbaum, MD
Chief Medical Officer
Invitae
Dee Anna Smith
CEO
Sarah Cannon and Sarah Cannon Research Institute
Benjamin Solomon, MD, FACMG
Managing Director
GeneDx
The only multi-stakeholder gathering focused on solving the data, digital infrastructure, and economic challenges facing precision medicine
Intimate, carefully curated, invitation-only gathering
Full spectrum of stakeholders
Focused on needs and solutions
Collaborative, discussion-oriented format
Chatham-house rules — non-attribution
No vendors or marketing lists
Published conference summary and recommendations
The only multi-stakeholder gathering focused on solving the data, digital infrastructure, and the economic challenges facing precision medicine
Intimate, carefully curated, invitation-only gathering
Full spectrum of stakeholders
Focused on needs and solutions
Collaborative, discussion-oriented format
Chatham-house rules — non-attribution
No vendors or marketing lists
Published conference summary and recommendations
Identify and resolve practical barriers facing precision medicine by
- Improving the capture of clinical effectiveness and economic value data
- Simplifying the test ordering and resulting workflow for clinicians, hospitals and labs
- Streamlining the genetic test billing, adjudication and payment process
- Reducing the frequency of misordered tests and surprise bills for patients
- Empowering patients to harness the insights in their genetic makeup for greater health
Lee N. Newcomer, MD
SVP, Oncology and Genetics
UnitedHealthcare
Robert C. Green, MD, MPH
Director, Genomes2People
Division of Genetics at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School
Suzanne Belinson, PhD, MPH
Executive Director
Blue Cross and Blue Shield Association
Mary E. Freivogel, MS, CGC
President
National Society of Genetic Counselors
Dan Roden, MD
Senior Vice President, Personalized Medicine
Vanderbilt University Medical Center
Nicole Boice
Founder & CEO
Global Genes
Paul W. Radensky, MD
Partner
McDermott Will & Emery
Carlos Bustamante, PhD
Chair, Department of Biomedical Data Science
Stanford University
David McCallie, MD
SVP, Medical Informatics
Cerner
Edward Abrahams, PhD
President
Personalized Medicine Coalition
Lisa Schlager
VP, Community Affairs & Public Policy
FORCE (Facing Our Risk of Cancer Empowered)
Taha Kass-Hout, MD
Former 1st Chief Health Informatics Officer
U.S. Food and Drug Administration (FDA)
Mara Aspinall
CEO
Health Catalysts
Robert Nussbaum, MD
Chief Medical Officer
Invitae
[<!–[if lte IE 8]>
<script charset=”utf-8″ type=”text/javascript” src=”//js.hsforms.net/forms/v2-legacy.js”></script>
<![endif]–>
<script charset=”utf-8″ type=”text/javascript” src=”//js.hsforms.net/forms/v2.js”></script>
<script>
hbspt.forms.create({
portalId: ‘2278050’,
formId: ’14dce719-0b2f-47dc-9af7-29979805110b’
});
</script>]